17alpha-ethynylestradiol increases expression ISO RGD:620516 6480464 Ethinyl Estradiol results in increased expression of DNAJC5 mRNA CTD PMID:29097150 17beta-estradiol affects expression ISO RGD:1344057 6480464 Estradiol affects the expression of DNAJC5 mRNA CTD PMID:22574217 17beta-estradiol increases expression ISO RGD:1344057 6480464 Estradiol results in increased expression of DNAJC5 mRNA CTD PMID:23019147 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DNAJC5 mRNA CTD PMID:21570461 , PMID:24680724 3,4-methylenedioxymethamphetamine increases expression EXP 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of DNAJC5 mRNA CTD PMID:20188158 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of DNAJC5 mRNA CTD PMID:18648102 6-propyl-2-thiouracil decreases expression ISO RGD:620516 6480464 Propylthiouracil results in decreased expression of DNAJC5 mRNA CTD PMID:24780913 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of DNAJC5 mRNA CTD PMID:19770486 aflatoxin B2 increases methylation ISO RGD:1344057 6480464 aflatoxin B2 results in increased methylation of DNAJC5 intron CTD PMID:30157460 ammonium chloride affects expression ISO RGD:620516 6480464 Ammonium Chloride affects the expression of DNAJC5 mRNA CTD PMID:16483693 antirheumatic drug decreases expression ISO RGD:1344057 6480464 Antirheumatic Agents results in decreased expression of DNAJC5 mRNA CTD PMID:24449571 arsane affects methylation ISO RGD:1344057 6480464 Arsenic affects the methylation of DNAJC5 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1344057 6480464 Arsenic affects the methylation of DNAJC5 gene CTD PMID:25304211 arsenic(3+) affects methylation ISO RGD:1344057 6480464 Arsenic affects the methylation of DNAJC5 gene CTD PMID:25304211 benzo[a]pyrene increases mutagenesis ISO RGD:1344057 6480464 Benzo(a)pyrene results in increased mutagenesis of DNAJC5 gene CTD PMID:25435355 benzo[a]pyrene affects methylation ISO RGD:1344057 6480464 Benzo(a)pyrene affects the methylation of DNAJC5 intron CTD PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1344057 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene decreases methylation ISO RGD:1344057 6480464 benzo(e)pyrene results in decreased methylation of DNAJC5 intron CTD PMID:30157460 bisphenol A increases expression ISO RGD:620516 6480464 bisphenol A results in increased expression of DNAJC5 mRNA CTD PMID:25181051 , PMID:29097150 carbamazepine affects expression ISO RGD:1344057 6480464 Carbamazepine affects the expression of DNAJC5 mRNA CTD PMID:24752500 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon affects the expression of DNAJC5 mRNA, Nanotubes, Carbon analog affects the expression of DNAJC5 mRNA CTD PMID:25554681 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of DNAJC5 mRNA CTD PMID:25620056 cobalt dichloride increases expression ISO RGD:620516 6480464 cobaltous chloride results in increased expression of DNAJC5 mRNA CTD PMID:24386269 CU-O LINKAGE decreases expression ISO RGD:1344057 6480464 cupric oxide results in decreased expression of DNAJC5 mRNA CTD PMID:22077320 deoxynivalenol increases phosphorylation EXP 6480464 deoxynivalenol results in increased phosphorylation of DNAJC5 protein CTD PMID:23352502 diclofenac affects expression ISO RGD:1344057 6480464 Diclofenac affects the expression of DNAJC5 mRNA CTD PMID:24752500 doxorubicin decreases expression ISO RGD:1344057 6480464 Doxorubicin results in decreased expression of DNAJC5 mRNA CTD PMID:29803840 ethanol multiple interactions EXP 6480464 Ethanol affects the expression of and affects the splicing of DNAJC5 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1344057 6480464 Ethyl Methanesulfonate results in increased expression of DNAJC5 mRNA CTD PMID:23649840 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of DNAJC5 mRNA CTD PMID:21318169 fenofibrate multiple interactions EXP 6480464 PPARA protein affects the reaction [Fenofibrate results in increased expression of DNAJC5 mRNA] CTD PMID:21318169 formaldehyde increases expression ISO RGD:1344057 6480464 Formaldehyde results in increased expression of DNAJC5 mRNA CTD PMID:23649840 gamma-hexachlorocyclohexane decreases expression ISO RGD:620516 6480464 Hexachlorocyclohexane results in decreased expression of DNAJC5 mRNA CTD PMID:17785943 gamma-tocopherol increases expression EXP 6480464 Tocopherols results in increased expression of DNAJC5 mRNA CTD PMID:17654050 gold atom multiple interactions ISO RGD:1344057 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of DNAJC5 mRNA CTD PMID:28433809 gold(0) multiple interactions ISO RGD:1344057 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of DNAJC5 mRNA CTD PMID:28433809 gold(1+) multiple interactions ISO RGD:1344057 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of DNAJC5 mRNA CTD PMID:28433809 imipramine increases expression ISO RGD:1344057 6480464 Imipramine results in increased expression of DNAJC5 mRNA, Imipramine results in increased expression of DNAJC5 protein CTD PMID:11257428 lead(0) affects expression ISO RGD:1344057 6480464 Lead affects the expression of DNAJC5 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1344057 6480464 Lead affects the expression of DNAJC5 mRNA CTD PMID:28903495 methapyrilene decreases methylation ISO RGD:1344057 6480464 Methapyrilene results in decreased methylation of DNAJC5 intron CTD PMID:30157460 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of DNAJC5 mRNA CTD PMID:18502557 methyl methanesulfonate increases expression ISO RGD:1344057 6480464 Methyl Methanesulfonate results in increased expression of DNAJC5 mRNA CTD PMID:23649840 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of DNAJC5 mRNA CTD PMID:17562736 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of DNAJC5 mRNA CTD PMID:23091169 phlorizin decreases expression EXP 6480464 Phlorhizin results in decreased expression of DNAJC5 mRNA CTD PMID:22538082 potassium dichromate increases expression ISO RGD:1344057 6480464 Potassium Dichromate results in increased expression of DNAJC5 protein CTD PMID:23718831 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of DNAJC5 mRNA CTD PMID:23186747 sertraline increases expression ISO RGD:1344057 6480464 Sertraline results in increased expression of DNAJC5 mRNA, Sertraline results in increased expression of DNAJC5 protein CTD PMID:11257428 succimer multiple interactions EXP 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DNAJC5 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DNAJC5 mRNA CTD PMID:21641980 , PMID:26378955 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of DNAJC5 mRNA CTD PMID:27339419 tocopherol increases expression EXP 6480464 Tocopherols results in increased expression of DNAJC5 mRNA CTD PMID:17654050 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of DNAJC5 mRNA CTD PMID:19042947 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of DNAJC5 mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:1344057 6480464 Valproic Acid results in increased expression of DNAJC5 mRNA CTD PMID:23179753
Biological Process chaperone-mediated protein folding IDA 2290270 (MGI:MGI:4939561, PMID:21151134) MGI MGI:MGI:4939561 , PMID:21151134 chaperone-mediated protein folding IMP 2290270 (MGI:MGI:4939561, PMID:21151134) MGI MGI:MGI:4939561 , PMID:21151134 negative regulation of neuron apoptotic process IGI MGI:MGI:1277151 , MGI:MGI:1889011 2290270 (MGI:MGI:3690829, PMID:16269331) MGI MGI:MGI:3690829 , PMID:16269331 regulation of synaptic vesicle cycle IMP 2290270 (MGI:MGI:5440402, PMID:22500637) MGI MGI:MGI:5440402 , PMID:22500637 regulation of synaptic vesicle cycle IDA 2290270 (MGI:MGI:5440402, PMID:22500637) MGI MGI:MGI:5440402 , PMID:22500637 Cellular Component anchored component of synaptic vesicle membrane ISO RGD:620516 2290270 MGI GO_REF:0000096, MGI:MGI:4417868 membrane IEA UniProtKB-KW:KW-0472 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 neuromuscular junction IMP 2290270 (MGI:MGI:5440402, PMID:22500637) SynGO MGI:MGI:5440402 , PMID:22500637 neuromuscular junction IDA 2290270 (MGI:MGI:5440402, PMID:22500637) SynGO MGI:MGI:5440402 , PMID:22500637 plasma membrane ISO UniProtKB:Q9H3Z4 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 presynapse IMP 2290270 (MGI:MGI:4939561, PMID:21151134) SynGO MGI:MGI:4939561 , PMID:21151134 presynapse IDA 2290270 (MGI:MGI:4939561, PMID:21151134) MGI MGI:MGI:4939561 , PMID:21151134 synaptic vesicle IDA 2290270 (MGI:MGI:3613132, PMID:16407767) MGI MGI:MGI:3613132 , PMID:16407767 Molecular Function ATP-dependent protein binding ISO RGD:620516 2290270 RGD GO_REF:0000096, MGI:MGI:4417868 protein binding IPI UniProtKB:Q80TN5 2290270 (MGI:MGI:5640908, PMID:25253725) UniProtKB MGI:MGI:5640908 , PMID:25253725 protein binding IPI UniProtKB:Q9CWU2 2290270 (MGI:MGI:5640908, PMID:25253725) UniProtKB MGI:MGI:5640908 , PMID:25253725
Gene-Chemical Interaction Annotations
